American Society of Clinical Oncology. Mental confusion or delirium. Accessed at cancer.net. Content is no longer available.
Grant PC, Levy K, Rossi JL, Lattimer TA. End-of-life dreams and visions: initial guidelines and recommendations to support dreams and visions at the end of life. J Palliat Med. 2023; 26(5):640-648.
Hession A, Luckett T, Currow D, Barbato M. Nurses' encounters with patients having end-of-life dreams and visions in an acute care setting—a cross-sectional survey study. J Adv Nurs. 2024; 80(8):3266-3277.
Hui D, De La Rosa A, Tsai JS, et al. Proportional sedation for persistent agitated delirium in palliative care: a randomized clinical trial. JAMA Oncol. 2025; 11(9).
Jackson D, Le Lagadec D, Cleary M. Hypoactive delirium: the critical need for collaboration between families and nurses in prevention, recognition and care. J Adv Nurs. 2025.
Klankluang W, Tongsai S, Sriphirom C, et al. The prevalence, associated factors, clinical impact, and state of diagnosis of delirium in palliative care patients. Support Care Cancer. 2021; 29(12):7513-7521.
National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Palliative Care. v1.2026. Accessed at www.nccn.org/ on September 25, 2026.
National Cancer Institute (NCI). Delirium: Cancer treatment side effect. Accessed at https://www.cancer.gov/about-cancer/treatment/side-effects/memory/delirium-pdq on October 1, 2026.
Sanders JJ, Downar J. Managing agitated delirium at the end of life—a knockout trial. JAMA Oncol. 2025; 11(9).
Thomas C, Alici Y, Breitbart W, et al. Drugs, delirium, and ethics at the end of life. J Am Geriatr Soc. 2024; 72(7):1963-1972.